학술논문
The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1fusion oncogene in rhabdomyosarcoma
Document Type
Article
Author
Bharathy, Narendra; Berlow, Noah E.; Wang, Eric; Abraham, Jinu; Settelmeyer, Teagan P.; Hooper, Jody E.; Svalina, Matthew N.; Ishikawa, Yoshihiro; Zientek, Keith; Bajwa, Zia; Goros, Martin W.; Hernandez, Brian S.; Wolff, Johannes E.; Rudek, Michelle A.; Xu, Linping; Anders, Nicole M.; Pal, Ranadip; Harrold, Alexandria P.; Davies, Angela M.; Ashok, Arya; Bushby, Darnell; Mancini, Maria; Noakes, Christopher; Goodwin, Neal C.; Ordentlich, Peter; Keck, James; Hawkins, Douglas S.; Rudzinski, Erin R.; Chatterjee, Bishwanath; Bächinger, Hans Peter; Barr, Frederic G.; Liddle, Jennifer; Garcia, Benjamin A.; Mansoor, Atiya; Perkins, Theodore J.; Vakoc, Christopher R.; Michalek, Joel E.; Keller, Charles
Source
Science Signaling; November 2018, Vol. 11 Issue: 557
Subject
Language
ISSN
19450877; 19379145
Abstract
The HDAC inhibitor entinostat sensitizes a subset of rhabdomyosarcomas to chemotherapy.